2008 European Guideline on HIV testing (Q56782771)

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Understanding recent increases in the incidence of sexually transmitted infections in men having sex with men: changes in risk behavior from risk avoidance to risk reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Antiretroviral treatment strategies and immune reconstitution in treatment-naïve HIV-infected patients with advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Relation between the HIV and the re-emerging syphilis epidemic among MSM in Germany: an analysis based on anonymous surveillance data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Lymphogranuloma venereum emerging in men who have sex with men in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Use of a leaflet to replace verbal pretest discussion for HIV: effects and acceptability

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

False-positive result from a Bayer Versant human immunodeficiency virus type 1 branched-DNA viral load assay, with a possible role for light leakage after inadequate maintenance of the analyzer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

A rapid review of rapid HIV antibody tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Repeatedly false-negative rapid HIV test results in a patient with undiagnosed advanced AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

HIV self-testing: a time to revise current policy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Use of laboratory tests and clinical symptoms for identification of primary HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Changes in the risk of death after HIV seroconversion compared with mortality in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Reducing the risk of mother-to-child human immunodeficiency virus transmission: past successes, current progress and challenges, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438

To notify or not to notify: STD patients' perspectives of partner notification in Seattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FIJSA.2008.008438